TrialBlood2015

A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).

Philip Young-Ill Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.